BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26958802)

  • 41. Substance abuse interventions for parents involved in the child welfare system: evidence and implications.
    Osterling KL; Austin MJ
    J Evid Based Soc Work; 2008; 5(1-2):157-89. PubMed ID: 19064448
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Healthcare services utilization among people with intellectual disability and comparison with the general population.
    Maltais J; Morin D; Tassé MJ
    J Appl Res Intellect Disabil; 2020 May; 33(3):552-564. PubMed ID: 32064737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Health care access, utilization, and problems in a sample of former foster children: a longitudinal investigation.
    Jones L
    J Evid Based Soc Work; 2014; 11(3):275-90. PubMed ID: 24857556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid repeat pregnancy among women with intellectual and developmental disabilities: a population-based cohort study.
    Brown HK; Ray JG; Liu N; Lunsky Y; Vigod SN
    CMAJ; 2018 Aug; 190(32):E949-E956. PubMed ID: 30104188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mortality of People with Intellectual and Developmental Disabilities from Select US State Disability Service Systems and Medical Claims Data.
    Lauer E; McCallion P
    J Appl Res Intellect Disabil; 2015 Sep; 28(5):394-405. PubMed ID: 25994364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving access to substance abuse treatment services for consumers with AIDS: a formative evaluation.
    Cooper RL; Cloud R; Besel K; Bennett AJ
    J Evid Based Soc Work; 2010 Jan; 7(1):115-29. PubMed ID: 20178029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The uptake of secondary prevention by adults with intellectual and developmental disabilities.
    Ouellette-Kuntz H; Cobigo V; Balogh R; Wilton A; Lunsky Y
    J Appl Res Intellect Disabil; 2015 Jan; 28(1):43-54. PubMed ID: 25530573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recreational substance use patterns and co-morbid psychopathology in adults with intellectual disability.
    Chaplin E; Gilvarry C; Tsakanikos E
    Res Dev Disabil; 2011; 32(6):2981-6. PubMed ID: 21640553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uncovering health care inequalities among adults with intellectual and developmental disabilities.
    Ward RL; Nichols AD; Freedman RI
    Health Soc Work; 2010 Nov; 35(4):280-90. PubMed ID: 21171535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. National study of barriers to timely primary care and emergency department utilization among Medicaid beneficiaries.
    Cheung PT; Wiler JL; Lowe RA; Ginde AA
    Ann Emerg Med; 2012 Jul; 60(1):4-10.e2. PubMed ID: 22418570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes.
    Abadi MH; Shamblen SR; Courser M; Johnson KW; Thompson K; Young L; Browne T
    Ethn Health; 2015; 20(5):453-73. PubMed ID: 24920072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lessons from the great molasses flood of Boston.
    Fray D; Waldman HB
    Alpha Omegan; 2012; 105(1-2):9-10. PubMed ID: 23930325
    [No Abstract]   [Full Text] [Related]  

  • 54. Individual and system-related factors associated with the costs of intellectual and developmental disabilities.
    Crowder SA; Melton DJ
    Tenn Med; 2012 Sep; 105(8):49-51. PubMed ID: 22978152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of identification when measuring performance in addiction treatment.
    Garnick D; Horgan C; Mark TL; Lee M; Acevedo A; Neager S; O'Brien P; Hashmi A; Marder B; Miller K
    Subst Abus; 2019; 40(3):263-267. PubMed ID: 30913002
    [No Abstract]   [Full Text] [Related]  

  • 56. Substance use and abuse among mentally retarded persons: a comparison of patients and a survey population.
    Westermeyer J; Phaobtong T; Neider J
    Am J Drug Alcohol Abuse; 1988; 14(1):109-23. PubMed ID: 3265026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disconnected lives: Women with intellectual disabilities in conflict with the law.
    Levine KA; Proulx J; Schwartz K
    J Appl Res Intellect Disabil; 2018 Mar; 31(2):249-258. PubMed ID: 28718998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Beyond Parity: Medicaid Policy and Improving Access to Effective Substance Use Disorder Treatment.
    Gyurina CH
    Med Care; 2020 Feb; 58(2):99-100. PubMed ID: 31895309
    [No Abstract]   [Full Text] [Related]  

  • 59. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.
    Green CA; Polen MR; Dickinson DM; Lynch FL; Bennett MD
    J Subst Abuse Treat; 2002 Dec; 23(4):285-95. PubMed ID: 12495790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Capacity of adults with intellectual disabilities to consent to sexual relationships.
    Murphy GH; O'Callaghan A
    Psychol Med; 2004 Oct; 34(7):1347-57. PubMed ID: 15697061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.